Mill Capital Management’s Quest Diagnostics DGX Stock Holding History

Mill Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$317K	Hold	1,620	–	–	0.02%	105
2025 Q4	$281K	Hold	1,620	–	–	0.02%	111
2025 Q3	$309K	Hold	1,620	–	–	0.02%	106
2025 Q2	$291K	Hold	1,620	–	–	0.02%	106
2025 Q1	$274K	Hold	1,620	–	–	0.02%	106
2024 Q4	$244K	Hold	1,620	–	–	0.02%	108
2024 Q3	$252K	Sell	1,620 -188	-10%	-$28.1K	0.02%	107
2024 Q2	$247K	Hold	1,808	–	–	0.02%	105
2024 Q1	$241K	Hold	1,808	–	–	0.02%	106
2023 Q4	$249K	Sell	1,808 -125	-6%	-$16.4K	0.02%	104
2023 Q3	$236K	Hold	1,933	–	–	0.02%	105
2023 Q2	$272K	Hold	1,933	–	–	0.03%	105
2023 Q1	$273K	Hold	1,933	–	–	0.03%	112
2022 Q4	$302K	Hold	1,933	–	–	0.03%	106
2022 Q3	$237K	Hold	1,933	–	–	0.03%	109
2022 Q2	$257K	Hold	1,933	–	–	0.03%	112
2022 Q1	$265K	Hold	1,933	–	–	0.03%	117
2021 Q4	$334K	Buy	+1,933	New	+$294K	0.03%	99

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Mill Capital Management's DGX Position: Q1 2026 in Review

Mill Capital Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,620 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #105.

Mill Capital Management first reported a position in DGX in Q4 2021 and has held it in 18 quarters since. The position peaked at $334K in Q4 2021. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Mill Capital Management held 1,620 shares of Quest Diagnostics worth $317K as of Q1 2026.
Mill Capital Management left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.02% of Mill Capital Management's portfolio in Q1 2026, its #105 holding.
Mill Capital Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 18 quarters since.
Mill Capital Management's Quest Diagnostics position peaked at $334K in Q4 2021.
1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Mill Capital Management's 13F filing for Q1 2026, filed 4 May 2026.